Comparison of the effectiveness of cyclophosphamide and rituximab treatment in patients with systemic sclerosis–related interstitial lung diseases: a retrospective, observational cohort study

被引：0
|
作者：
Deniz Demir Yılmaz
Sermin Borekci
Benan Musellim
机构：
[1] Istanbul University-Cerrahpasa,Department of Pulmonary Diseases, Cerrahpasa Medical Faculty
来源：
Clinical Rheumatology | 2021年 / 40卷
关键词：
Cyclophosphamide; Rituximab; Systemic sclerosis–related interstitial lung diseases;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4071 / 4079
页数：8
相关论文
共 50 条
  • [21] TREATMENT OF PRIMARY SJOGREN'S SYNDROME-RELATED INTERSTITIAL LUNG DISEASE: A RETROSPECTIVE COHORT STUDY
    Amlani, Barkha
    Elsayed, Ghada
    Barvalia, Umang
    Kanne, Jeffrey P.
    Meyer, Keith C.
    Sandbo, Nathan
    Li, Zhanhai
    McCoy, Sara S.
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2020, 37 (02) : 136 - 147
  • [22] A pilot study of intermittent intravenous cyclophosphamide for the treatment of systemic sclerosis associated lung disease
    Várai, G
    Earle, L
    Jimenez, SA
    Steiner, RM
    Varga, J
    JOURNAL OF RHEUMATOLOGY, 1998, 25 (07) : 1325 - 1329
  • [23] Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study
    Sumida, Hayakazu
    Asano, Yoshihide
    Tamaki, Zenshiro
    Aozasa, Naohiko
    Taniguchi, Takashi
    Toyama, Tetsuo
    Takahashi, Takehiro
    Ichimura, Yohei
    Noda, Shinji
    Akamata, Kaname
    Saigusa, Ryosuke
    Miyazaki, Miki
    Kuwano, Yoshihiro
    Yanaba, Koichi
    Yoshizaki, Ayumi
    Sato, Shinichi
    JOURNAL OF DERMATOLOGY, 2018, 45 (12) : 1425 - 1433
  • [24] Rituximab in Patients with Systemic Sclerosis-associated Interstitial Lung Disease A Systematic Review and Meta-Analysis
    Macrea, Madalina
    Ghazipura, Marya
    Herman, Derrick
    Barnes, Hayley
    Knight, Shandra L.
    Silver, Richard M.
    Montesi, Sydney B.
    Raghu, Ganesh
    Hossain, Tanzib
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2024, 21 (02) : 317 - 327
  • [25] Cyclophosphamide in Patients with Systemic Sclerosis-associated Interstitial Lung Disease A Systematic Review and Meta-Analysis
    Barnes, Hayley
    Ghazipura, Marya
    Herman, Derrick
    Macrea, Madalina
    Knight, Shandra L.
    Silver, Richard M.
    Montesi, Sydney B.
    Raghu, Ganesh
    Hossain, Tanzib
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2024, 21 (01) : 122 - 135
  • [26] COMPARISON OF THE RITUXIMAB (RTM) EFFICACY IN MONOTHERAPY REGIMEN AND IN COMBINATION WITH IMMUNOSUPPRESSANTS IN SYSTEMIC SCLEROSIS (SSC) WITH INTERSTITIAL LUNG DISEASE (ILD)
    Koneva, O.
    Ananieva, L.
    Garzanova, L.
    Desinova, O.
    Ovsyannikova, O.
    Starovoytova, M.
    CHEST, 2020, 157 (06) : 374A - 374A
  • [27] Treatment of progressive forms of multiple sclerosis by cyclophosphamide:: a cohort study of 490 patients
    Zephir, H
    de Seze, J
    Duhamel, A
    Debouverie, M
    Hautecoeur, P
    Lebrun, C
    Malikova, I
    Pelletier, J
    Sénéchal, O
    Vermersch, P
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2004, 218 (1-2) : 73 - 77
  • [28] Rituximab as a rescue treatment added on mycophenolate mofetil background therapy in progressive systemic sclerosis associated interstitial lung disease unresponsive to conventional immunosuppression
    Narvaez, Javier
    LLuch, Judit
    Molina-Molina, Maria
    Vicens-Zygmunt, Vanesa
    Luburich, Patricio
    Anibal Yanez, Marcos
    Nolla, Joan M.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2020, 50 (05) : 977 - 987
  • [29] A retrospective cohort study reporting rituximab treatment for 33 patients with immunobullous disease
    Watson, Nicola
    Carrozzo, Marco
    Hampton, Philip
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2021, 50 (01) : 92 - 97
  • [30] Systemic sclerosis: comparison of efficacy of oral cyclophosphamide and azathioprine on skin score and pulmonary involvement—a retrospective study
    Hadi Poormoghim
    Nader Rezaei
    Zeinab Sheidaie
    Ali Reza Almasi
    Maziar Moradi-Lakeh
    Simin Almasi
    Elham Andalib
    Rheumatology International, 2014, 34 : 1691 - 1699
12345